Search Clinical Trials ?


Trials Open: 6
Cancer Type: Chronic myelogenous Leukemia (CML)
Protocol No.Title
16-HEM-09/INCB18424-271Ruxolitinib + Corticosteroids for treatment of Steroid-Refractory aGVHD
MCC-16-MULTI-18Genomic Testing for Patients with Refractory Cancer to Determine Treatment
MCC-16-MULTI-19Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
NCI-CIRB-AALL1621InO in Children and AYA with RR D22+ B-ALL
NCI-CIRB-P2C-IL057-9706To Assess Nivolumab in Eliminating Minimal Residual Disease & Maintain Remission After Chemotherapy.